Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

The Barts Cancer Institute Lecturer at NCRI Symposium 2011: Jeff Settleman

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
91 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 9, 2011

Barts Cancer Institute sponsors the premier plenary lecture that opens the NCRI Symposium 2011. Jeff Settleman, Senior Director for Oncology Discovery at Genentech Inc reveals the cutting edge technology now being applied to identify the optimal targeted drugs for patients with a wide range of malignancies. Combining high-throughput assays with an unrivalled collection of annoted cell lines, as well as the latest -omics technology has enabled the boundaries of what is possible in drug development to be pushed beyond imagination.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more